1
|
Court L, Aggarwal A, Burger H, Cardenas C, Chung C, Douglas R, du Toit M, Jaffray D, Jhingran A, Mejia M, Mumme R, Muya S, Naidoo K, Ndumbalo J, Nealon K, Netherton T, Nguyen C, Olanrewaju N, Parkes J, Shaw W, Trauernicht C, Xu M, Yang J, Zhang L, Simonds H, Beadle BM. Addressing the Global Expertise Gap in Radiation Oncology: The Radiation Planning Assistant. JCO Glob Oncol 2023; 9:e2200431. [PMID: 37471671 PMCID: PMC10581646 DOI: 10.1200/go.22.00431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2022] [Revised: 02/08/2023] [Accepted: 04/24/2023] [Indexed: 07/22/2023] Open
Abstract
PURPOSE Automation, including the use of artificial intelligence, has been identified as a possible opportunity to help reduce the gap in access and quality for radiotherapy and other aspects of cancer care. The Radiation Planning Assistant (RPA) project was conceived in 2015 (and funded in 2016) to use automated contouring and treatment planning algorithms to support the efforts of oncologists in low- and middle-income countries, allowing them to scale their efforts and treat more patients safely and efficiently (to increase access). DESIGN In this review, we discuss the development of the RPA, with a particular focus on clinical acceptability and safety/risk across jurisdictions as these are important indicators for the successful future deployment of the RPA to increase radiotherapy availability and ameliorate global disparities in access to radiation oncology. RESULTS RPA tools will be offered through a webpage, where users can upload computed tomography data sets and download automatically generated contours and treatment plans. All interfaces have been designed to maximize ease of use and minimize risk. The current version of the RPA includes automated contouring and planning for head and neck cancer, cervical cancer, breast cancer, and metastases to the brain. CONCLUSION The RPA has been designed to bring high-quality treatment planning to more patients across the world, and it may encourage greater investment in treatment devices and other aspects of cancer treatment.
Collapse
Affiliation(s)
- Laurence Court
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Ajay Aggarwal
- Guy's and St Thomas' Hospital, London, United Kingdom
| | - Hester Burger
- Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
| | | | - Christine Chung
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Raphael Douglas
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Monique du Toit
- Tygerberg Hospital, Stellenbosch University, Cape Town, South Africa
| | - David Jaffray
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Anuja Jhingran
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Michael Mejia
- Benavides Cancer Institute, University of Santo Tomas, Manila, Philippines
| | - Raymond Mumme
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | | | - Komeela Naidoo
- Tygerberg Hospital, Stellenbosch University, Cape Town, South Africa
| | | | - Kelly Nealon
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | | | | | - Niki Olanrewaju
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Jeannette Parkes
- Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
| | - Willie Shaw
- University of the Free State, Bloemfontein, South Africa
| | | | - Melody Xu
- University of California San Francisco, San Francisco, CA
| | - Jinzhong Yang
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Lifei Zhang
- The University of Texas MD Anderson Cancer Center, Houston, TX
| | | | | |
Collapse
|
2
|
Plan quality association between dummy run and individual case review in a prospective multi-institutional clinical trial of postoperative cervical cancer patients treated with intensity-modulated radiotherapy: Japan Clinical Oncology Group study (JCOG1402). Radiother Oncol 2023; 183:109630. [PMID: 36934892 DOI: 10.1016/j.radonc.2023.109630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2022] [Revised: 03/08/2023] [Accepted: 03/10/2023] [Indexed: 03/19/2023]
Abstract
BACKGROUND AND PURPOSE The Japan Clinical Oncology Group (JCOG) 1402 conducted a multicenter clinical trial of postoperative intensity-modulated radiotherapy (IMRT) for high-risk uterine cervical cancer patients. We assess effectiveness of the quality assurance (QA) program in central review through dummy runs (DRs) performed before patient enrollment and post-treatment individual case review (ICR), and clarify the pitfalls in treatment planning. MATERIAL AND METHODS The ICRs were conducted using the same QA program as the DR for 214 plans. The deviations were compared with those demonstrated in the DRs, and the pitfalls were clarified. Fifteen face-to-face meetings were held with physicians at participating institutions to provide feedback. RESULTS Two-hundred and eighty-nine deviations and nine violations were detected in the 214 plans. The patterns of the deviations observed in the ICRs were similar to that in the DR. Frequent deviations were observed in clinical target volume (CTV) delineations, 50% in the DRs and 35% in the ICRs, respectively. In the ICRs, approximately 1.4 deviations/violations were observed per plan, which was lower than DR. Nine violations included inaccurate CTV delineation and improper PTV (planning target volume) margin, which had risks in loco-regional failures by inadequate dose coverage. CONCLUSIONS Our developed QA program commonly used in DR and ICR clarified the pitfalls in treatment plans. Although the frequent deviations in CTV delineations were observed in the ICR, the deviations decreased compared to that in the DR. More specified face-to-face meetings with participating institutions will be necessary to maintain the quality of IMRT in the clinical protocol. TRIAL REGISTRATION Japanese Clinical Trial Registry #: UMIN000027017 at https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000030672;language=J.
Collapse
|
3
|
Trivellato S, Caricato P, Pellegrini R, Montanari G, Daniotti MC, Bordigoni B, Faccenda V, Panizza D, Meregalli S, Bonetto E, Arcangeli S, De Ponti E. Comprehensive dosimetric and clinical evaluation of lexicographic optimization-based planning for cervical cancer. Front Oncol 2022; 12:1041839. [PMID: 36465394 PMCID: PMC9709287 DOI: 10.3389/fonc.2022.1041839] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2022] [Accepted: 10/25/2022] [Indexed: 11/01/2023] Open
Abstract
AIM In this study, a not yet commercially available fully-automated lexicographic optimization (LO) planning algorithm, called mCycle (Elekta AB, Stockholm, Sweden), was validated for cervical cancer. MATERIAL AND METHODS Twenty-four mono-institutional consecutive treatment plans (50 Gy/25 fx) delivered between November 2019 and April 2022 were retrospectively selected. The automatic re-planning was performed by mCycle, implemented in the Monaco TPS research version (v5.59.13), in which the LO and Multicriterial Optimization (MCO) are coupled with Monte Carlo calculation. mCycle optimization follows an a priori assigned priority list, the so-called Wish List (WL), representing a dialogue between the radiation oncologist and the planner, setting hard constraints and following objectives. The WL was tuned on a patient subset according to the institution's clinical protocol to obtain an optimal plan in a single optimization. This robust WL was then used to automatically re-plan the remaining patients. Manual plans (MP) and mCycle plans (mCP) were compared in terms of dose distributions, complexity (modulation complexity score, MCS), and delivery accuracy (perpendicular diode matrices, gamma analysis-passing ratio, PR). Their clinical acceptability was assessed through the blind choice of two radiation oncologists. Finally, a global quality score index (SI) was defined to gather into a single number the plan evaluation process. RESULTS The WL tuning requested four patients. The 20 automated re-planning tasks took three working days. The median optimization and calculation time can be estimated at 4 h and just over 1 h per MP and mCP, respectively. The dose comparison showed a comparable organ-at-risk spare. The planning target volume coverage increased (V95%: MP 98.0% [95.6-99.3]; mCP 99.2%[89.7-99.9], p >0.05). A significant increase has been registered in MCS (MP 0.29 [0.24-0.34]; mCP 0.26 [0.23-0.30], p <0.05) without affecting delivery accuracy (PR (3%/3mm): MP 97.0% [92.7-99.2]; mCP 97.1% [95.0-98.6], p >0.05). In the blind choice, all mCP results were clinically acceptable and chosen over MP in more than 75% of cases. The median SI score was 0.69 [0.41-0.84] and 0.73 [0.51-0.82] for MP and mCP, respectively (p >0.05). CONCLUSIONS mCycle plans were comparable to clinical manual plans, more complex but accurately deliverable and registering a similar SI. Automated plans outperformed manual plans in blinded clinical choice.
Collapse
Affiliation(s)
- Sara Trivellato
- Medical Physics Department, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
| | - Paolo Caricato
- Medical Physics Department, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
- Department of Physics, University of Milan, Milan, Italy
| | | | - Gianluca Montanari
- Medical Physics Department, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
| | - Martina Camilla Daniotti
- Medical Physics Department, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
- Department of Physics, University of Milan, Milan, Italy
| | - Bianca Bordigoni
- Medical Physics Department, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
- Department of Physics, University of Milan Bicocca, Milan, Italy
| | - Valeria Faccenda
- Medical Physics Department, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
- Department of Physics, University of Milan, Milan, Italy
| | - Denis Panizza
- Medical Physics Department, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
- School of Medicine and Surgery, University of Milan Bicocca, Milan, Italy
| | - Sofia Meregalli
- School of Medicine and Surgery, University of Milan Bicocca, Milan, Italy
- Department of Radiation Oncology, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
| | - Elisa Bonetto
- Department of Radiation Oncology, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
| | - Stefano Arcangeli
- School of Medicine and Surgery, University of Milan Bicocca, Milan, Italy
- Department of Radiation Oncology, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
| | - Elena De Ponti
- Medical Physics Department, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy
- School of Medicine and Surgery, University of Milan Bicocca, Milan, Italy
| |
Collapse
|
4
|
Tao C, Liu B, Li C, Zhu J, Yin Y, Lu J. A novel knowledge-based prediction model for estimating an initial equivalent uniform dose in semi-auto-planning for cervical cancer. Radiat Oncol 2022; 17:151. [PMID: 36038941 PMCID: PMC9426003 DOI: 10.1186/s13014-022-02120-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Accepted: 08/22/2022] [Indexed: 12/24/2022] Open
Abstract
Background We developed a novel concept, equivalent uniform length (EUL), to describe the relationship between the generalized equivalent uniform dose (EUD) and the geometric anatomy around a tumor target. By correlating EUL with EUD, we established two EUD–EUL knowledge-based (EEKB) prediction models for the bladder and rectum that predict initial EUD values for generating quality treatment plans. Methods EUL metrics for the rectum and bladder were extracted and collected from the intensity-modulated radiotherapy therapy (IMRT) plans of 60 patients with cervical cancer. The two EEKB prediction models were built using linear regression to establish the relationships between EULr and EUDr (EUL and EUD of rectum) and EULb, and EUDb (EUL and EUD of bladder), respectively. The EE plans were optimized by incorporating the predicted initial EUD parameters for the rectum and bladder with the conventional pinnacle auto-planning (PAP) initial dose parameters for other organs. The efficiency of the predicted initial EUD values were then evaluated by comparing the consistency and quality of the EE plans, PAP plans (based on default PAP initial parameters), and manual plans (designed manually by different dosimetrists) for a sample of 20 patients. Results Linear regression analyses showed a significant correlation between EUL and EUD (R2 = 0.79 and 0.69 for EUDb and EUDr, respectively). In a sample of 20 patients, the average bladder V40 and V50 derived from the EE plans were significantly lower (V40: 30.00 ± 5.76, V50: 14.36 ± 4.00) than the V40 and V50 values derived from manual plans (V40: 36.03 ± 8.02, V50: 19.02 ± 5.42). Compared with the PAP plans, the EE plans produced significantly lower average V30 and Dmean values for the bladder (V30: 50.55 ± 6.33, Dmean: 31.48 ± 1.97 Gy). Conclusions Our EEKB prediction models predicted reasonable initial EUD values for the rectum and bladder based on patient-specific geometric EUL values, thereby improving optimization and planning efficiency. Supplementary Information The online version contains supplementary material available at 10.1186/s13014-022-02120-4.
Collapse
Affiliation(s)
- Cheng Tao
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440, Jiyan Road, Jinan, 250117, China
| | - Bo Liu
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440, Jiyan Road, Jinan, 250117, China
| | - Chengqiang Li
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440, Jiyan Road, Jinan, 250117, China
| | - Jian Zhu
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440, Jiyan Road, Jinan, 250117, China.
| | - Yong Yin
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440, Jiyan Road, Jinan, 250117, China.
| | - Jie Lu
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440, Jiyan Road, Jinan, 250117, China.
| |
Collapse
|
5
|
Development and evaluation of a three-step automatic planning technique for lung Stereotactic Body Radiation Therapy based on performance examination of advanced settings in Pinnacle's auto-planning module. Appl Radiat Isot 2022; 189:110434. [DOI: 10.1016/j.apradiso.2022.110434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2022] [Revised: 08/16/2022] [Accepted: 08/24/2022] [Indexed: 11/22/2022]
|
6
|
Rhee DJ, Jhingran A, Huang K, Netherton TJ, Fakie N, White I, Sherriff A, Cardenas CE, Zhang L, Prajapati S, Kry SF, Beadle BM, Shaw W, O'Reilly F, Parkes J, Burger H, Trauernicht C, Simonds H, Court LE. Clinical acceptability of fully automated external beam radiotherapy for cervical cancer with three different beam delivery techniques. Med Phys 2022; 49:5742-5751. [PMID: 35866442 PMCID: PMC9474595 DOI: 10.1002/mp.15868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2021] [Revised: 06/16/2022] [Accepted: 07/12/2022] [Indexed: 12/02/2022] Open
Abstract
Purpose To fully automate CT‐based cervical cancer radiotherapy by automating contouring and planning for three different treatment techniques. Methods We automated three different radiotherapy planning techniques for locally advanced cervical cancer: 2D 4‐field‐box (4‐field‐box), 3D conformal radiotherapy (3D‐CRT), and volumetric modulated arc therapy (VMAT). These auto‐planning algorithms were combined with a previously developed auto‐contouring system. To improve the quality of the 4‐field‐box and 3D‐CRT plans, we used an in‐house, field‐in‐field (FIF) automation program. Thirty‐five plans were generated for each technique on CT scans from multiple institutions and evaluated by five experienced radiation oncologists from three different countries. Every plan was reviewed by two of the five radiation oncologists and scored using a 5‐point Likert scale. Results Overall, 87%, 99%, and 94% of the automatically generated plans were found to be clinically acceptable without modification for the 4‐field‐box, 3D‐CRT, and VMAT plans, respectively. Some customizations of the FIF configuration were necessary on the basis of radiation oncologist preference. Additionally, in some cases, it was necessary to renormalize the plan after it was generated to satisfy radiation oncologist preference. Conclusion Approximately, 90% of the automatically generated plans were clinically acceptable for all three planning techniques. This fully automated planning system has been implemented into the radiation planning assistant for further testing in resource‐constrained radiotherapy departments in low‐ and middle‐income countries.
Collapse
Affiliation(s)
- Dong Joo Rhee
- The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA.,Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Anuja Jhingran
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Kai Huang
- The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, USA.,Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Tucker J Netherton
- Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Nazia Fakie
- Division of Radiation Oncology and Medical Physics, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
| | - Ingrid White
- Radiotherapy Department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
| | - Alicia Sherriff
- Department of Oncology, University of the Free State, Bloemfontein, South Africa
| | - Carlos E Cardenas
- Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Lifei Zhang
- Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Surendra Prajapati
- Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Stephen F Kry
- Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Beth M Beadle
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA
| | - William Shaw
- Department of Medical Physics (G68), University of the Free State, Bloemfontein, South Africa
| | - Frederika O'Reilly
- Department of Medical Physics (G68), University of the Free State, Bloemfontein, South Africa
| | - Jeannette Parkes
- Division of Radiation Oncology and Medical Physics, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
| | - Hester Burger
- Division of Radiation Oncology and Medical Physics, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
| | - Chris Trauernicht
- Division of Medical Physics, Stellenbosch University, Tygerberg Academic Hospital, Cape Town, South Africa
| | - Hannah Simonds
- Division of Radiation Oncology, Stellenbosch University, Tygerberg Academic Hospital, Cape Town, South Africa
| | - Laurence E Court
- Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| |
Collapse
|
7
|
Kang Z, Fu L, Liu J, Shi L, Li Y. A practical method to improve the performance of knowledge-based VMAT planning for endometrial and cervical cancer. Acta Oncol 2022; 61:1012-1018. [PMID: 35793274 DOI: 10.1080/0284186x.2022.2093615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
Abstract
PURPOSE The aim of this work was to demonstrate a practical and effective method to improve the performance of RapidPlan (RP) model. METHODS 203 consecutive clinical VMAT plans (P0) for cervical and endometrial cancer were used to train an RP model (M0). The plans were then reoptimized by M0 to generate 203 new plans (P1). Compared with P0, 150 plans with a lower mean dose (MD) of bladder, rectum and PBM were selected from P1 to configure a new RP model (M1). A final RP model (M2) was trained using plans in M1 and the remaining 53 plans from P1 (excluding OARs with worse MD) and the corresponding plans from P0 (only including OARs with better MD). The models were validated on the mentioned 53 plans (closed-loop set) and 46 patient cohorts outside the training library (open-loop set). p < 0.05 was considered statistically significant. RESULTS For closed-loop validation, the difference of D2%, D98% and CI95% between groups was of no statistical significance, the homogeneity index (HI) was lower in the groups of RP models (p < 0.05). The MD of all OARs decreased monotonically in the sequence of the clinical group, group M0, M1 and M2, except the MD of bowel in M1 and MD of LFH in M2. Similarly, for open-loop validation, there was no significant difference in D2%, D98% and HI between groups, but CI95% was larger in the clinical group (p < 0.05). The MD of all OARs decreased monotonically in the sequence of the clinical group, group M0, M1 and M2, with the exception of bowel in M1. CONCLUSION The practical method of incorporating plan data of better-sparing OARs from both the clinical VMAT plans and the re-optimized plans could further improve the performance of the RP model.
Collapse
Affiliation(s)
- Zheng Kang
- Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China.,Xiamen Key Laboratory of Radiation Oncology, Xiamen, China
| | - Lirong Fu
- Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China
| | - Jun Liu
- Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China
| | - Liwan Shi
- Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China.,Teaching Hospital of Fujian Medical University, Xiamen, China
| | - Yimin Li
- Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China.,Xiamen Key Laboratory of Radiation Oncology, Xiamen, China.,Teaching Hospital of Fujian Medical University, Xiamen, China
| |
Collapse
|
8
|
Fu Y, Zhang H, Morris ED, Glide-Hurst CK, Pai S, Traverso A, Wee L, Hadzic I, Lønne PI, Shen C, Liu T, Yang X. Artificial Intelligence in Radiation Therapy. IEEE TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES 2022; 6:158-181. [PMID: 35992632 PMCID: PMC9385128 DOI: 10.1109/trpms.2021.3107454] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Artificial intelligence (AI) has great potential to transform the clinical workflow of radiotherapy. Since the introduction of deep neural networks, many AI-based methods have been proposed to address challenges in different aspects of radiotherapy. Commercial vendors have started to release AI-based tools that can be readily integrated to the established clinical workflow. To show the recent progress in AI-aided radiotherapy, we have reviewed AI-based studies in five major aspects of radiotherapy including image reconstruction, image registration, image segmentation, image synthesis, and automatic treatment planning. In each section, we summarized and categorized the recently published methods, followed by a discussion of the challenges, concerns, and future development. Given the rapid development of AI-aided radiotherapy, the efficiency and effectiveness of radiotherapy in the future could be substantially improved through intelligent automation of various aspects of radiotherapy.
Collapse
Affiliation(s)
- Yabo Fu
- Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA
| | - Hao Zhang
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
| | - Eric D. Morris
- Department of Radiation Oncology, University of California-Los Angeles, Los Angeles, CA 90095, USA
| | - Carri K. Glide-Hurst
- Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53792, USA
| | - Suraj Pai
- Maastricht University Medical Centre, Netherlands
| | | | - Leonard Wee
- Maastricht University Medical Centre, Netherlands
| | | | - Per-Ivar Lønne
- Department of Medical Physics, Oslo University Hospital, PO Box 4953 Nydalen, 0424 Oslo, Norway
| | - Chenyang Shen
- Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75002, USA
| | - Tian Liu
- Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA
| | - Xiaofeng Yang
- Department of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA
| |
Collapse
|
9
|
Tsang DS, Tsui G, McIntosh C, Purdie T, Bauman G, Dama H, Laperriere N, Millar BA, Shultz DB, Ahmed S, Khandwala M, Hodgson DC. A pilot study of machine-learning based automated planning for primary brain tumours. Radiat Oncol 2022; 17:3. [PMID: 34991634 PMCID: PMC8734345 DOI: 10.1186/s13014-021-01967-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2021] [Accepted: 12/15/2021] [Indexed: 11/10/2022] Open
Abstract
Purpose High-quality radiotherapy (RT) planning for children and young adults with primary brain tumours is essential to minimize the risk of late treatment effects. The feasibility of using automated machine-learning (ML) to aid RT planning in this population has not previously been studied. Methods and materials We developed a ML model that identifies learned relationships between image features and expected dose in a training set of 95 patients with a primary brain tumour treated with focal radiotherapy to a dose of 54 Gy in 30 fractions. This ML method was then used to create predicted dose distributions for 15 previously-treated brain tumour patients across two institutions, as a testing set. Dosimetry to target volumes and organs-at-risk (OARs) were compared between the clinically-delivered (human-generated) plans versus the ML plans. Results The ML method was able to create deliverable plans in all 15 patients in the testing set. All ML plans were generated within 30 min of initiating planning. Planning target volume coverage with 95% of the prescription dose was attained in all plans. OAR doses were similar across most structures evaluated; mean doses to brain and left temporal lobe were lower in ML plans than manual plans (mean difference to left temporal, – 2.3 Gy, p = 0.006; mean differences to brain, – 1.3 Gy, p = 0.017), whereas mean doses to right cochlea and lenses were higher in ML plans (+ 1.6–2.2 Gy, p < 0.05 for each). Conclusions Use of an automated ML method to aid RT planning for children and young adults with primary brain tumours is dosimetrically feasible and can be successfully used to create high-quality 54 Gy RT plans. Further evaluation after clinical implementation is planned. Supplementary Information The online version contains supplementary material available at 10.1186/s13014-021-01967-3.
Collapse
Affiliation(s)
- Derek S Tsang
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
| | - Grace Tsui
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
| | - Chris McIntosh
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
| | - Thomas Purdie
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
| | - Glenn Bauman
- London Regional Cancer Program, London, ON, Canada
| | - Hitesh Dama
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
| | - Normand Laperriere
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
| | - Barbara-Ann Millar
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
| | - David B Shultz
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
| | - Sameera Ahmed
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
| | - Mohammad Khandwala
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada
| | - David C Hodgson
- Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
| |
Collapse
|
10
|
Schmidt MC, Pryser EA, Baumann BC, Yaqoub MM, Raman CA, Szentivanyi P, Michalski JM, Gay HA, Knutson NC, Hugo G, Sajo E, Zygmanski P, Mazur T, Dise J, Cammin J, Laugeman E, Reynoso FJ. Development and Implementation of an Open Source Template Interpretation Class Library for Automated Treatment Planning. Pract Radiat Oncol 2021; 12:e153-e160. [PMID: 34839048 DOI: 10.1016/j.prro.2021.11.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Revised: 10/31/2021] [Accepted: 11/03/2021] [Indexed: 11/18/2022]
Abstract
PURPOSE Widespread implementation of automated treatment planning in radiation therapy remains elusive due to variability in clinic and physician preferences making it difficult to ensure consistent plan parameters. We have developed an open-source class library with the aim to improve efficiency and consistency for automated treatment planning in radiation therapy. METHODS AND MATERIALS An open source class library has been developed that interprets clinical templates within a commercial treatment planning system into a treatment plan for automated planning. This code was leveraged for the automated planning of 39 patients and retrospectively compared to the 78 clinically approved manual plans. RESULTS From the initial 39 patients, 74 of 78 plans were successfully generated without manual intervention. Target dose was more homogenous for automated plans, with an average homogeneity index of 3.30 vs 3.11 for manual and automated plans, respectively (p = 0.107). Generalized equivalent uniform dose decreased in the femurs and rectum for automated plans, with mean gEUD of 3746 cGy vs 3338 cGy (p ≤ 0.001) and 5761 cGy vs 5634 cGy (p ≤ 0.001) for femurs and rectum, respectively. Dose metrics for bladder and rectum (V6500 cGy and V4000 cGy) show recognizable but insignificant improvements. All automated plans delivered for quality assurance passed a gamma analysis (>95%) with an average composite pass rate of 99.3% and 98.8% for pelvis and prostate plans, respectively. Deliverability parameters such as total monitor units and aperture complexity indicate deliverable plans. CONCLUSIONS Prostate cancer and pelvic node radiotherapy can be automated using VMAT planning and clinical templates based on a standardized clinical workflow. The class library developed in this study conveniently interfaces between the plan template and the treatment planning system to automatically generate high quality plans on customizable templates.
Collapse
Affiliation(s)
- Matthew C Schmidt
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri; Department of Physics, University of Massachusetts Lowell, Lowell, Massachusetts.
| | - Eleanor A Pryser
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Brian C Baumann
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Mahmoud M Yaqoub
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Caleb A Raman
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | | | - Jeff M Michalski
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Hiram A Gay
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Nels C Knutson
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Geoffrey Hugo
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Erno Sajo
- Department of Physics, University of Massachusetts Lowell, Lowell, Massachusetts
| | - Piotr Zygmanski
- Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
| | - Thomas Mazur
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Joseph Dise
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Jochen Cammin
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Eric Laugeman
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| | - Francisco J Reynoso
- Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri
| |
Collapse
|
11
|
Hirashima H, Nakamura M, Mukumoto N, Ashida R, Fujii K, Nakamura K, Nakajima A, Sakanaka K, Yoshimura M, Mizowaki T. Reducing variability among treatment machines using knowledge-based planning for head and neck, pancreatic, and rectal cancer. J Appl Clin Med Phys 2021; 22:245-254. [PMID: 34151503 PMCID: PMC8292706 DOI: 10.1002/acm2.13316] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2021] [Revised: 05/14/2021] [Accepted: 05/17/2021] [Indexed: 11/18/2022] Open
Abstract
Purpose This study aimed to assess dosimetric indices of RapidPlan model‐based plans for different energies (6, 8, 10, and 15 MV; 6‐ and 10‐MV flattening filter‐free), multileaf collimator (MLC) types (Millennium 120, High Definition 120, dual‐layer MLC), and disease sites (head and neck, pancreatic, and rectal cancer) and compare these parameters with those of clinical plans. Methods RapidPlan models in the Eclipse version 15.6 were used with the data of 28, 42, and 20 patients with head and neck, pancreatic, and rectal cancer, respectively. RapidPlan models of head and neck, pancreatic, and rectal cancer were created for TrueBeam STx (High Definition 120) with 6 MV, TrueBeam STx with 10‐MV flattening filter‐free, and Clinac iX (Millennium 120) with 15 MV, respectively. The models were used to create volumetric‐modulated arc therapy plans for a 10‐patient test dataset using all energy and MLC types at all disease sites. The Holm test was used to compare multiple dosimetric indices in different treatment machines and energy types. Results The dosimetric indices for planning target volume and organs at risk in RapidPlan model‐based plans were comparable to those in the clinical plan. Furthermore, no dose difference was observed among the RapidPlan models. The variability among RapidPlan models was consistent regardless of the treatment machines, MLC types, and energy. Conclusions Dosimetric indices of RapidPlan model‐based plans appear to be comparable to the ones based on clinical plans regardless of energies, MLC types, and disease sites. The results suggest that the RapidPlan model can generate treatment plans independent of the type of treatment machine.
Collapse
Affiliation(s)
- Hideaki Hirashima
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Mitsuhiro Nakamura
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.,Division of Medical Physics, Department of Information Technology and Medical Engineering, Faculty of Human Health Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Nobutaka Mukumoto
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Ryo Ashida
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Kota Fujii
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Kiyonao Nakamura
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Aya Nakajima
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Katsuyuki Sakanaka
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Michio Yoshimura
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Takashi Mizowaki
- Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| |
Collapse
|
12
|
Swamidas J, Pradhan S, Chopra S, Panda S, Gupta Y, Sood S, Mohanty S, Jain J, Joshi K, Ph R, Gurram L, Mahantshetty U, Prakash Agarwal J. Development and clinical validation of Knowledge-based planning for Volumetric Modulated Arc Therapy of cervical cancer including pelvic and para aortic fields. PHYSICS & IMAGING IN RADIATION ONCOLOGY 2021; 18:61-67. [PMID: 34258410 PMCID: PMC8254199 DOI: 10.1016/j.phro.2021.05.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Revised: 05/12/2021] [Accepted: 05/14/2021] [Indexed: 12/24/2022]
Abstract
A knowledge-based planning model was configured for VMAT of cervical cancer. Knowledge-based plans were comparable, and for some OARs, outperformed clinical plans. Improved organ sparing was observed, when individual patient geometry was considered.
Background and Purpose Knowledge-based planning (KBP) is based on a model to estimate dose-volume histograms, configured using a library of historical treatment plans to efficiently create high quality plans. The aim was to report configuration and validation of KBP for Volumetric Modulated Arc Therapy of cervical cancer. Materials and methods A KBP model was configured from the institutional database (n = 125), including lymph node positive (n = 60) and negative (n = 65) patients. KBP Predicted plans were compared with Clinical Plans (CP) and Re-plans (Predicted plan as a base-plan) to validate the model. Model quality was quantified using coefficient of determination R2, mean square error (MSE), standard two-tailed paired t-test and Wilcoxon signed rank test. Results Estimation capability of the model was good for the bowel bag (MSE = 0.001, R2 = 0.84), modest for the bladder (MSE = 0.008) and poor for the rectum (MSE = 0.02 R2 = 0.78). KBP resulted in comparable target coverage, superior organ sparing as compared to CP. Re-plans outperformed CP for the bladder, V30 (66 ± 11% vs 74 ± 11%, p < .001), V40 (48 ± 14% vs 52 ± 14%, p < .001), however sparing was modest for the bowel bag V30 (413 ± 191cm3 vs 445 ± 208cm3, p = .037) V40 (199 ± 105cm3 vs 218 ± 127cm3, p = .031). All plans were comparable for rectum, while KBP resulted in significant sparing for spinal cord, kidneys and femoral heads. Conclusion KBP yielded comparable and for some organs superior performance compared to CP resulting in conformal and homogeneous target coverage. Improved organ sparing was observed when individual patient geometry was considered.
Collapse
Affiliation(s)
- Jamema Swamidas
- Department of Radiation Oncology, ACTREC, Tata Memorial Centre, Mumbai, India.,Homi Bhabha National Institute, Mumbai, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Sangram Pradhan
- Department of Radiotherapy, All India Institute of Medical Sciences, New Delhi, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Supriya Chopra
- Department of Radiation Oncology, ACTREC, Tata Memorial Centre, Mumbai, India.,Homi Bhabha National Institute, Mumbai, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Subhajit Panda
- Department of Radiation Oncology, ACTREC, Tata Memorial Centre, Mumbai, India.,Homi Bhabha National Institute, Mumbai, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Yashna Gupta
- Department of Radiotherapy, All India Institute of Medical Sciences, Rishikesh, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Sahil Sood
- Homi Bhabha National Institute, Mumbai, India.,Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Samarpita Mohanty
- Homi Bhabha National Institute, Mumbai, India.,Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Jeevanshu Jain
- Department of Radiation Oncology, ACTREC, Tata Memorial Centre, Mumbai, India.,Homi Bhabha National Institute, Mumbai, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Kishore Joshi
- Department of Radiation Oncology, ACTREC, Tata Memorial Centre, Mumbai, India.,Homi Bhabha National Institute, Mumbai, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Reena Ph
- Department of Radiation Oncology, ACTREC, Tata Memorial Centre, Mumbai, India.,Homi Bhabha National Institute, Mumbai, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Lavanya Gurram
- Homi Bhabha National Institute, Mumbai, India.,Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Umesh Mahantshetty
- Homi Bhabha National Institute, Mumbai, India.,Department of Radiation Oncology, Homi Bhabha Cancer Hospital and Research Centre, Vishakapatnam, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| | - Jai Prakash Agarwal
- Homi Bhabha National Institute, Mumbai, India.,Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India.,Department of Medical Physics, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
| |
Collapse
|
13
|
Rhee DJ, Jhingran A, Kisling K, Cardenas C, Simonds H, Court L. Automated Radiation Treatment Planning for Cervical Cancer. Semin Radiat Oncol 2020; 30:340-347. [PMID: 32828389 DOI: 10.1016/j.semradonc.2020.05.006] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The radiation treatment-planning process includes contouring, planning, and reviewing the final plan, and each component requires substantial time and effort from multiple experts. Automation of treatment planning can save time and reduce the cost of radiation treatment, and potentially provides more consistent and better quality plans. With the recent breakthroughs in computer hardware and artificial intelligence technology, automation methods for radiation treatment planning have achieved a clinically acceptable level of performance in general. At the same time, the automation process should be developed and evaluated independently for different disease sites and treatment techniques as they are unique from each other. In this article, we will discuss the current status of automated radiation treatment planning for cervical cancer for simple and complex plans and corresponding automated quality assurance methods. Furthermore, we will introduce Radiation Planning Assistant, a web-based system designed to fully automate treatment planning for cervical cancer and other treatment sites.
Collapse
Affiliation(s)
- Dong Joo Rhee
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX.
| | - Anuja Jhingran
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Kelly Kisling
- Department of Radiation Medicine and Applied Sciences, The University of California, San Diego, San Diego, CA
| | - Carlos Cardenas
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Hannah Simonds
- Department of Radiation Oncology, Tygerberg Hospital/University of Stellenbosch, Stellenbosch, South Africa
| | - Laurence Court
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
14
|
Bai H, Zhu S, Wu X, Liu X, Chen F, Yan J. Study on the ability of 3D gamma analysis and bio-mathematical model in detecting dose changes caused by dose-calculation-grid-size (DCGS). Radiat Oncol 2020; 15:161. [PMID: 32631380 PMCID: PMC7336463 DOI: 10.1186/s13014-020-01603-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2020] [Accepted: 06/23/2020] [Indexed: 02/06/2023] Open
Abstract
Objective To explore the efficacy and sensitivity of 3D gamma analysis and bio-mathematical model for cervical cancer in detecting dose changes caused by dose-calculation-grid-size (DCGS). Methods 17 patients’ plans for cervical cancer were enrolled (Pinnacle TPS, VMAT), and the DCGS was changed from 2.0 mm to 5.0 mm to calculate the planned dose respectively. The dose distribution calculated by DCGS = 2.0 mm as the “reference” data set (RDS), the dose distribution calculated by the rest DCGS as the“measurement”data set (MDS), the 3D gamma passing rates and the (N) TCPs of the all structures under different DCGS were obtained, and then analyze the ability of 3D gamma analysis and (N) TCP model in detecting dose changes and what factors affect this ability. Results The effect of DCGS on planned dose was obvious. When the gamma standard was 1.0 mm, 1.0 and 10.0%, the difference of the results of the DCGS on dose-effect could be detected by 3D gamma analysis (all p value < 0.05). With the decline of the standard, 3D gamma analysis’ ability to detect this difference shows weaker. When the standard was 1.0 mm, 3.0 and 10.0%, the p value of > 0.05 accounted for the majority. With DCGS = 2.0 mm being RDS, ∆gamma-passing-rate presented the same trend with ∆(N) TCPs of all structures except for the femurs only when the 1.0 mm, 1.0 and 10.0% standards were adopted for the 3D gamma analysis. Conclusions The 3D gamma analysis and bio-mathematical model can be used to analyze the effect of DCGS on the planned dose. For comparison, the former’s detection ability has a lot to do with the designed standard, and the latter’s capability is related to the parameters and calculated accuracy instrinsically.
Collapse
Affiliation(s)
- Han Bai
- Department of Radiation Oncology, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, No.519 Kunzhou, Road, Xishan District, Kunming, Yunnan, China
| | - Sijin Zhu
- Department of Radiation Oncology, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, No.519 Kunzhou, Road, Xishan District, Kunming, Yunnan, China
| | - Xingrao Wu
- Department of Radiation Oncology, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, No.519 Kunzhou, Road, Xishan District, Kunming, Yunnan, China.
| | - Xuhong Liu
- Department of Radiation Oncology, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, No.519 Kunzhou, Road, Xishan District, Kunming, Yunnan, China
| | - Feihu Chen
- Department of Radiation Oncology, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, No.519 Kunzhou, Road, Xishan District, Kunming, Yunnan, China
| | - Jiawen Yan
- Department of Radiation Oncology, Yunnan Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, No.519 Kunzhou, Road, Xishan District, Kunming, Yunnan, China
| |
Collapse
|